These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15692966)

  • 1. Careful attention to blood sampling as a preanalytical determinant of circulating matrix metalloproteinase 9 to avoid misinterpretations: comment on the article by Ainiala et al.
    Jung K
    Arthritis Rheum; 2005 Feb; 52(2):673-4; author reply 674. PubMed ID: 15692966
    [No Abstract]   [Full Text] [Related]  

  • 2. Validating sampling methods for measurement of circulating matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1.
    Zhang RY; Cui W; Zhao KJ; Tang YQ; Li L
    Pancreas; 2010 Aug; 39(6):937; author reply 937-8. PubMed ID: 20664481
    [No Abstract]   [Full Text] [Related]  

  • 3. Consideration of important preanalytical conditions for the assessment of circulating matrix metalloproteinase-9.
    John M; Jung K
    Am J Respir Crit Care Med; 2005 Jul; 172(2):254; author reply 254. PubMed ID: 16002574
    [No Abstract]   [Full Text] [Related]  

  • 4. Preanalytical pitfalls of blood sampling to measure true circulating matrix metalloproteinase 9 and tissue inhibitors of matrix metalloproteinases.
    Jung K; Gerlach RF; Tanus-Santos JE
    Clin Chim Acta; 2006 Nov; 373(1-2):180-1; author reply 182. PubMed ID: 16616058
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum or plasma samples? The "Cinderella" role of blood collection procedures: preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation.
    Mannello F
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):611-4. PubMed ID: 18354094
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating gelatinase B (MMP-9)--the impact of the preanalytical step of blood collection.
    Jung K; Lein M; Roemer A; Lichtinghagen R
    Matrix Biol; 2002 Aug; 21(5):381-2. PubMed ID: 12225801
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating matrix metalloproteinase-9 levels in atherosclerotic vascular disease: a possible measurement of systemic or specific disease pathophysiology?
    Lim HS; Lip GY
    J Intern Med; 2008 Jun; 263(6):620-2. PubMed ID: 18479262
    [No Abstract]   [Full Text] [Related]  

  • 8. Matrix metalloproteinases do not properly work as peripheral blood biomarkers without taking into account the preanalytical impact of blood sampling.
    Jung K
    Eur J Cardiothorac Surg; 2008 May; 33(5):944; author reply 945. PubMed ID: 18343680
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating matrix metalloproteinase-9 levels as a possible marker of aortic stiffness.
    Tanus-Santos JE; Gerlach RF
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):e127. PubMed ID: 16055752
    [No Abstract]   [Full Text] [Related]  

  • 10. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure.
    Gerlach RF; Tanus-Santos JE
    Am Heart J; 2006 Jul; 152(1):e9. PubMed ID: 16824824
    [No Abstract]   [Full Text] [Related]  

  • 11. Preanalytical aspects regarding the measurement of metalloproteinase-9 and tissue inhibitor or metalloproteinase-1 in blood.
    Alby C; Ben Abdesselam O; Foglietti MJ; Beaudeux JL
    Clin Chim Acta; 2002 Nov; 325(1-2):183-6. PubMed ID: 12367785
    [No Abstract]   [Full Text] [Related]  

  • 12. A strong note of caution in using matrix metalloproteinase-1 and its inhibitor, TIMP-1 in serum as biomarkers in systolic heart failure.
    Jung K
    J Intern Med; 2008 Sep; 264(3):291-3. PubMed ID: 18341527
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Chang YH; Lin IL; Tsay GJ; Yang SC; Yang TP; Ho KT; Hsu TC; Shiau MY
    Clin Biochem; 2008 Aug; 41(12):955-9. PubMed ID: 18471998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of circulating gelatinases (matrix metalloproteinase-2 and -9) are dependent on the conditions of blood collection.
    Meisser A; Cohen M; Bischof P
    Clin Chem; 2005 Jan; 51(1):274-6. PubMed ID: 15613733
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythomatosus.
    Robak E; Wierzbowska A; Chmiela M; Kulczycka L; Sysa-Jedrejowska A; Robak T
    Mediators Inflamm; 2006; 2006(1):17898. PubMed ID: 16864898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices.
    Mannello F; Tanus-Santos JE; Meschiari CA; Tonti GA
    Anal Biochem; 2008 Mar; 374(1):56-63. PubMed ID: 18082127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood.
    Mannello F; Jung K; Tonti GA; Canestrari F
    Clin Biochem; 2008 Dec; 41(18):1466-73. PubMed ID: 18926810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases.
    Jung K
    Clin Chem Lab Med; 2006; 44(4):500-2. PubMed ID: 16599848
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
    Bolton CE; Stone MD; Edwards PH; Duckers JM; Evans WD; Shale DJ
    Chron Respir Dis; 2009; 6(2):81-7. PubMed ID: 19411568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
    Benesová Y; Vasku A; Novotná H; Litzman J; Stourac P; Beránek M; Kadanka Z; Bednarík J
    Mult Scler; 2009 Mar; 15(3):316-22. PubMed ID: 19153173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.